|
|
Volumn 1, Issue 4, 2003, Pages 495-505
|
|
Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROBENZENE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
ROSUVASTATIN;
SULFONAMIDE;
COMPARATIVE STUDY;
DRUG INTERACTION;
HUMAN;
HYPERLIPIDEMIA;
METABOLIC SYNDROME X;
REVIEW;
TREATMENT OUTCOME;
DRUG INTERACTIONS;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
METABOLIC SYNDROME X;
PYRIMIDINES;
SULFONAMIDES;
TREATMENT OUTCOME;
|
|
EID: 1542748421
PISSN: 14779072
EISSN: None
Source Type: Journal
DOI: 10.1586/14779072.1.4.495 Document Type: Review |
|
Times cited : (101)
|
|
References (66)
|
